Pauline Byakika–Kibwika (née Pauline Byakika) is a Ugandan specialist physician, internist, epidemiologist, academic and researcher. She was appointed and announced as the vice chancellor of Mbarara University of Science and technology. in August 2024 after emerging the best out of the 5 candidates shortlisted for the job[1].[2][3] She previously served as a Professor of Medicine at Makerere University College of Health Sciences.[4] From 2017 until 2019, she served as the Vice President of the Uganda Medical Association, a professional industry association that champions medical doctors' interests in Uganda.[5]
Pauline Byakika | |
|---|---|
| Born | 1973 (age 50–51) Uganda |
| Alma mater | |
| Occupations | |
| Years active | 2000–present |
| Known for | Academics and Research |
| Title | Professor of Medicine Makerere University College of Health Sciences |
Background and education
editShe was born in the Eastern Region of Uganda circa 1973. After attending local schools, she was admitted to the Makerere University, where she studied human medicine. She graduated with a Bachelor of Medicine and Bachelor of Surgery (MBChB) degree in 1999. She followed that with a Master of Medicine (MMed) degree in Internal Medicine, also from Makerere University. Her third degree was a Master of Science (MSc) in Clinical Epidemiology and Biostatistics, obtained from Makerere University. She also holds a Doctor of Philosophy (PhD) in Clinical Pharmacology obtained from the Trinity College Dublin, in Dublin, Ireland.[5][6] Her PhD thesis analyses the drug-to-drug interactions between antimalarials and Anti-retroviral drugs.[4]
Career
editByakika started out as a medical officer at Mulago National Referral Hospital and over time rose in status through senior house officer (SHO), registrar and finally consultant in the department of Medicine at the hospital.[4]
She has concurrently taught at Makerere University College of Health Sciences, which uses Mulago Hospital as its teaching hospital. She has risen through the ranks, over the years, from research associate, assistant lecturer, lecturer, senior lecturer, to her current rank of associate professor, as of August 2018. She has also worked at the University's Infectious Diseases Institute.[4]
In 2017, Pauline Byakika, MBChB, MMed (Medicine), MSc, PhD, was elected to serve as the Vice President of the Uganda Medical Association, for the next two years.[7] In addition to her duties, as a member of the nine-person executive committee, she was a member of the 55-person National Governing Council of the Association.[8]
On 5th August 2024, she was named as the third vice chancellor of Mbarara University of Science and Technology.[2][3]
Other considerations
editProfessor Byakika has authored or co-written over 40 peer-reviewed articles, in the areas of her medical expertise in different medical journals.[5]
See also
editReferences
edit- ^ "Prof. Pauline Byakika-Kibwika scored highest to be new MUST Vice Chancellor".
- ^ a b "Prof. Pauline Byakika-Kibwika Appointed as new Vice Chancellor of MUST". ChimpReports. 5 August 2024. Retrieved 5 August 2024.
- ^ a b Wetaka, Ahmed (5 August 2024). "Prof. Pauline Byakika-Kibwika Appointed New Vice Chancellor of MUST".
- ^ a b c d Tropical Diseases Research at WHO (22 August 2018). "TDR Global profile: Empowering Ugandan women to have medical and science careers". Geneva: World Health Organization (WHO). Retrieved 22 August 2018.
- ^ a b c Uganda Medical Association (22 August 2018). "Biography of Professor Pauline Byakika–Kibwika". Kampala: Uganda Medical Association. Retrieved 22 August 2018.
- ^ Byakika, Pauline (22 August 2018). "Biography of Pauline Byakika, MBChB, MMed (Medicine), MSc, PhD". Linkedin.com. Retrieved 22 August 2018.
- ^ Manishimwe, Wilson (21 December 2017). "Thugs attack Uganda Medical Association boss, admitted". New Vision. Kampala. Retrieved 22 August 2018.
- ^ Uganda Medical Association (March 2018). "Uganda Medical Association: Composition of the National Governing Council, As At March 2018". Kampala: Uganda Medical Association. Retrieved 22 August 2018.